Hercules Capital Archives

Hercules Capital Provides $50MM in Debt Financing to AmplifyBio

AmplifyBio augmented its balance sheet with non-dilutive debt financing, whereby it may borrow a principal amount of up to $50 million from Hercules Capital.

January 13, 2023 AmplifyBio | Bryan Jadot | Hercules Capital | J. Kelly Ganjei Ian Koplin

Silicon Valley Bank and Hercules Capital Provide $300MM Credit Facility to Oak Street Health

Silicon Valley Bank and Hercules Capital provided a $300 million credit facility to Oak Street Health, a network of value-based primary care centers for adults on Medicare. The financing is intended to provide Oak Street Health with operational and strategic capital for the next several years.

Hercules Capital Provides $125MM Debt Facility to Tricida

Tricida entered into a debt facility with Hercules Capital. The total amount of the debt facility is $125 million of which $100 million will be available for drawdown at Tricida’s option subject to the achievement of certain milestones.

October 20, 2022 Geoff Parker | Hercules Capital | Scott Bluestein | Tricida Ian Koplin

Hercules Capital Provides $200MM Term Loan Facility to Replimune Group

Replimune Group, a clinical stage biotechnology company pioneering the development of a novel class of tumor-directed oncolytic immunotherapies, obtained a $200 million non-dilutive term loan facility from Hercules Capital.

October 10, 2022 Armentum Partners | Bryan Jadot | Hercules Capital | Jean Franchi | Replimune Group Ian Koplin

Automation Anywhere Secures $200MM in Financing from Three Banks

Automation Anywhere, a global robotic process automation company, secured $200 million in financing from Silicon Valley Bank, SVB Capital and Hercules Capital. The financing is intended to provide operational and strategic capital for the next several years.

Hercules Capital Provides $125MM Term Loan Facility to Provention Bio

Provention Bio, a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, secured a term loan facility of up to $125 million with Hercules Capital.

September 1, 2022 Bryan Jadot | Hercules Capital | Jefferies | Provention Bio Ian Koplin

Hercules Capital Enters into $50MM Term Loan Agreement with Alladapt Immunotherapeutics

Alladapt Immunotherapeutics, a private, clinical-stage biopharmaceutical company developing prescription therapeutics to address IgE-mediated food allergy, entered into a term loan agreement for up to $50 million with Hercules Capital.

Hercules Capital Provides $175MM Term Loan to atai Life Sciences

atai Life Sciences, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, entered into a term loan facility for up to $175 million with Hercules Capital.

Hercules Capital and Silicon Valley Bank Provide $80MM Credit Facility for Gritstone bio

Gritstone bio, a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, entered into an $80 million credit facility with Hercules Capital and Silicon Valley Bank.

Hercules Capital Expands Credit Facility with MUFG Bank and SMBC to $720MM

Hercules Capital increased its existing credit facilities with MUFG Bank and Sumitomo Mitsui Banking Corporation from a combined $500 million to $720 million, subject to a borrowing base, leverage and other restrictions.

Tag Archives: Hercules Capital